Skip to main content

Table 3 Response according to genotyping of vascular endothelial growth factor

From: The relationship of Vascular endothelial growth factor gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX: VEGF polymorphism in gastric cancer

Genotype

Polymorphism

ORR

%

P*

−2578C/A

CC

41/116

35.3

0.798

 

CA

20/63

31.7

 
 

AA

3/11

27.3

 

−2489C/T

CC

41/116

35.3

0.812

 

CT

19/160

31.7

 
 

TT

4/14

28.6

 

−1498 T/C

TT

41/116

30.8

0.832

 

TC

19/61

31.1

 
 

CC

4/13

35.3

 

−634 G/C

GG

12/54

22.2

0.034

 

GC

30/93

32.3

 
 

CC

22/43

51.1

 

+936C/T

CC

46/135

34.1

0.852

 

CT

14/45

31.1

 
 

TT

4/10

40.0

 

+1612 G/A

GG

50/139

36.0

0.333

 

GA

12/47

25.5

 
 

AA

2/4

50.0

 
  1. *by Fisher’s exact and chi-square test.
  2. ORR: overall response rate.